Skip to main content
. 2017 Nov 8;15(1):783–788. doi: 10.3892/ol.2017.7359

Figure 2.

Figure 2.

Erlotinib causes chromatin condensation, karyopyknosis and upregulated apoptosis proteins dose-dependently in L-02 cells when L-02 cells were exposed to increasing doses of erlotinib for 48 h. (A) Fluorescence microscopic images of the nuclear morphology of L-02 cells, stained with DAPI. (B) The upregulation of c-caspase-3 and c-PARP analyzed by western blotting. Data are representative of three independent experiments. ERLO, erlotinib; c-, cleaved; PARP, poly (ADP-ribose) polymerase.